Search alternatives:
significant advancements » significant advancement (Expand Search), significant advantages (Expand Search), significant improvements (Expand Search)
alter disease » artery disease (Expand Search), cancer disease (Expand Search), canker disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 1 - 20 results of 20,124 for search '(( significantly ((alter disease) OR (teer decrease)) ) OR ( significant advancements decrease ))', query time: 0.58s Refine Results
  1. 1
    The expression of miR-122 is decreased as liver fibrosis progressed.

    The expression of miR-122 is decreased as liver fibrosis progressed. by Young Chang (3666829)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  2. 2
    Multivariate analysis of variables predicting advanced liver fibrosis.

    Multivariate analysis of variables predicting advanced liver fibrosis. by Young Chang (3666829)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  3. 3
    Significant alterations in the levels of coding editing sites in disease.

    Significant alterations in the levels of coding editing sites in disease. by Tomer D. Mann (15203465)

    Published 2023
    “…<p>Significant alterations in the levels of coding editing sites in disease.…”
    Save to List
    Saved in:
  4. 4
    The expression of miR-122 is downregulated in advanced liver fibrosis stages.

    The expression of miR-122 is downregulated in advanced liver fibrosis stages. by Young Chang (3666829)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 5
    Exosomal miR-122 shows a fair discriminative ability for advanced liver fibrosis.

    Exosomal miR-122 shows a fair discriminative ability for advanced liver fibrosis. by Young Chang (3666829)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  6. 6
    Actions of the main intrinsic laryngeal muscles and the laryngeal abnormalities in Parkinson’s disease.

    Actions of the main intrinsic laryngeal muscles and the laryngeal abnormalities in Parkinson’s disease. by Andrew Ma (4532494)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  7. 7
    Change in laryngeal measures with disease duration and UPDRS part III scores.

    Change in laryngeal measures with disease duration and UPDRS part III scores. by Andrew Ma (4532494)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 8
    N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease.

    N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. by Noelia Carballeda-Sangiao (2889611)

    Published 2020
    Save to List
    Saved in:
  9. 9
    Motif enrichment in significantly altered phospho-proteomic data.

    Motif enrichment in significantly altered phospho-proteomic data. by Jacob M. Wozniak (4900267)

    Published 2020
    Save to List
    Saved in:
  10. 10
    Phospho-protein Families with Numerous Significantly-Altered Phospho-peptides.

    Phospho-protein Families with Numerous Significantly-Altered Phospho-peptides. by Jacob M. Wozniak (4900267)

    Published 2020
    Save to List
    Saved in:
  11. 11
    Kinases predicted from significantly altered phospho-proteomic data.

    Kinases predicted from significantly altered phospho-proteomic data. by Jacob M. Wozniak (4900267)

    Published 2020
    Save to List
    Saved in:
  12. 12
    The laryngeal measures.

    The laryngeal measures. by Andrew Ma (4532494)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 13
    Comparison of the laryngeal measures during vocalization between pwPD and controls.

    Comparison of the laryngeal measures during vocalization between pwPD and controls. by Andrew Ma (4532494)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 14
    Demographic details.

    Demographic details. by Andrew Ma (4532494)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  15. 15
    JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER.

    JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER. by Kameljit K. Kalsi (16496511)

    Published 2023
    Save to List
    Saved in:
  16. 16
    Significantly altered protein identification list.

    Significantly altered protein identification list. by Emel Akgun (3938690)

    Published 2020
    Save to List
    Saved in:
  17. 17
    Image_1_T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease.TIF

    Image_1_T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease.TIF by Jiachuan Xiong (748476)

    Published 2021
    Save to List
    Saved in:
  18. 18
    Image_2_T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease.TIFF

    Image_2_T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease.TIFF by Jiachuan Xiong (748476)

    Published 2021
    Save to List
    Saved in:
  19. 19
    Transepithelial electrical resistance (TEER) (N = 6).

    Transepithelial electrical resistance (TEER) (N = 6). by Shirko Marcel Shokr (19173337)

    Published 2024
    “…<p><b>(A)</b> During the cultivation of SMC and ALI we observed significantly differences on day 18 (SMC: 9.61 kΩ*cm<sup>2</sup>; ALI: 7.73 kΩ*cm<sup>2</sup>; p<0.05) and day 25 (SMC: 8.19 kΩ*cm<sup>2</sup>; ALI: 6.44 kΩ*cm<sup>2</sup>; p<0.05) ALI cultures showed significantly decreased values compared to SMC. …”
    Save to List
    Saved in:
  20. 20
    Metabolites significantly altered in T2D at follow-up.

    Metabolites significantly altered in T2D at follow-up. by Mi Lai (8871431)

    Published 2020
    Save to List
    Saved in:

Search Tools: